β-Estradiol antagonizes the inhibitory effects of caffeine in BMMSCs via the ERβ-mediated cAMP-dependent PKA pathway

Toxicology. 2018 Feb 1:394:1-10. doi: 10.1016/j.tox.2017.11.015. Epub 2017 Nov 15.

Abstract

Caffeine negatively mediates bone homeostasis to cause bone loss and even osteoporosis. This phenomenon occurs in postmenopausal women with estrogen deficiency but not in healthy young women. In this study, we determined whether the effects of caffeine on bone homeostasis were antagonized by estrogen and the underlying mechanisms. In particular, because high levels of cAMP, an important second messenger, have been observed in postmenopausal women suffering from osteoporosis, we examined the role of cAMP in the effects of caffeine on bone homeostasis. In vivo study showed that caffeine accelerated bone loss in osteoporotic rats, whereas β-estradiol blunted the negative effect of caffeine on bone. In vitro study, we harvested bone marrow-derived mesenchymal stromal cells (BMMSCs) from osteoporotic rats. We found that caffeine and β-estradiol inversely affected BMMCSs proliferation, apoptosis, osteogenic lineage commitment, extracellular matrix synthesis and mineralization. These parameters were assessed according to the expression levels of osteogenic markers, alkaline phosphatase activity and Alizarin red staining. The deleterious effects of caffeine on BMMSCs were blunted by β-estradiol. The cAMP-dependent PKA pathway was found to be involved in regulating caffeine/β-estradiol-mediated cell growth, survival and osteogenesis. Additionally, after estrogen receptor (ER) β knockdown, the antagonistic effects of β-estradiol on caffeine were nearly abolished. These results indicated that by binding to ERβ, β-estradiol antagonizes the negative impacts of caffeine on cell growth and osteogenic differentiation in BMMSCs through the cAMP-dependent PKA signaling pathway.

Keywords: BMMSCs; Bone marrow-derived mesenchymal stromal cells; Caffeine; Er; Estrogen receptor; Osteoporosis; cAMP/PKA signaling; β-estradiol.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Marrow Cells / cytology
  • Bone Marrow Cells / drug effects*
  • Bone Marrow Cells / enzymology*
  • Bone and Bones / drug effects
  • Bone and Bones / enzymology
  • Bone and Bones / pathology
  • Caffeine / antagonists & inhibitors*
  • Caffeine / pharmacology
  • Cell Growth Processes / drug effects
  • Cell Survival / drug effects
  • Cells, Cultured
  • Cyclic AMP-Dependent Protein Kinases / metabolism*
  • Disease Models, Animal
  • Drug Interactions
  • Estradiol / pharmacology*
  • Estrogen Receptor beta
  • Female
  • Mesenchymal Stem Cells / cytology
  • Mesenchymal Stem Cells / drug effects*
  • Mesenchymal Stem Cells / enzymology*
  • Osteogenesis / drug effects
  • Osteoporosis / chemically induced
  • Osteoporosis / drug therapy
  • Osteoporosis / pathology
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley
  • Signal Transduction / drug effects

Substances

  • Estrogen Receptor beta
  • Caffeine
  • Estradiol
  • Cyclic AMP-Dependent Protein Kinases